Matthew I. Mace has been appointed to the Board of Directors of Precision Cardiovascular.
Extensive experience in cardiovascular innovation.
Matthew has over 15 years of experience in cardiovascular technologies.
A strategic addition to PCV's board.
Matthew Mace said "Precision Cardiovascular stands at a key moment, bridging cutting-edge research with real-world clinical impact."
Matthew's dual expertise in traditional cardiac devices and ML-driven solutions accelerates our ability to navigate complex regulatory landscapes.
The PCV advances toward clinical trials.
Matthew's appointment comes at a pivotal time as Precision Cardiovascular expands its pre-clinical work in minimally-invasive haemodynamic monitoring.
About precision cardiovascular.
The Precision Cardiovascular system integrates advanced sensor technology with machine learning to enable reliable and proactive cardiac care in everyday settings.
Email protected,Precision Cardiovascular, The Magdi Yacoub Institute, Heart Science Centre, Harefield Hospital.
Precision Cardiovascular is a company.
Do not sell or share my information.

Source prnewswire